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The aim of this study was to investigate magnetic resonance imaging (MRI) ﬁndings following autolo-
gous blood injection (ABI) for habitual temporomandibular joint (TMJ) dislocation. MRI was performed
one hour and four and twelve weeks after ABI, revealing three types of signiﬁcant ﬁndings. The ﬁrst type
was similar to hematoma and/or joint effusion in the articular capsule of the TMJ (type I). The second
showed sporadic and diffuse T2 emphasis around the TMJ capsule (type II). The third involved a
decreased range of condyle movement compared to before ABI (type III). Furthermore, we analyzed the
three types of signiﬁcant MRI ﬁndings.
At one hour after ABI, type I was Grade 0 in 0 of 14 patients, Grade 1 in 8, Grade 2 in 2, and Grade 3 in
4. Type II was seen in 9 of the 14 cases and type III in 8. After twelve weeks, all cases of type I were Grade
0, no type II cases were evident, and type III was seen in 11 cases. Injecting autologous blood into sur-
rounding TMJ tissues is an important factor in ABI. Minimally invasive treatment for habitual TMJ
dislocation using ABI around the TMJ capsule appears to represent a very effective and safe treatment.
 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights
reserved.1. Introduction
Dislocation of the temporomandibular joint (TMJ) is considered
to involve a combination of three factors: stretching of the masti-
catory muscles and capsular ligaments; a large articular tubercle;
and muscle spasm. Stretching of the mandibular and TMJ capsule
ligaments permits the mandibular condyle to move further ante-
riorly during mandibular opening, passing over the articular tu-
bercle. With some patients, as the extended articular tubercle
functions as a mechanical barrier, reduction of the condyle does not
occur. Once the condyle passes over the articular tubercle, muscle
spasm between the protractor muscles will continue to push the
condyle forward while the elevator muscles try to push the
mandible back, keeping the condyle anterior to the articular tu-
bercle. Return of the condyle head to the mandibular fossa thus
becomes difﬁcult (Hasson and Nahlieli, 2001).u, Osaka 540-0008, Japan.
shiro).
axillo-Facial Surgery. Published byVarious conservative methods can be used to treat habitual
dislocation of the TMJ. Non-surgical methods are usually applied
before any decision to perform surgery (LeClerc and Girald, 1943;
MacFarlane, 1977; McKelvey, 1950; Myrhaug, 1951; Schultz, 1937;
Segami et al., 1999). Various non-surgical treatment models have
been described in the past, including injection of a sclerosing so-
lution into the superior articular cavity (tincture of iodine, alcohol,
and picibanil) (Becker, 1954). However, that approach has not been
used in many cases due to the risk of adverse reactions such as
facial paralysis and traumatic arthritis (Kato et al., 2007; Machon
et al., 2009). Another procedure with less adverse reactions is the
use of botulinum toxin (Bakke et al., 2005), which is injected into
the lateral pterygoid muscle to block movement of the mandible. In
this way, displacement of the mandibular condyle is prevented
even when the mouth is opened excessively (Fu et al., 2010;
Vázquez Bouso et al., 2010).
Autologous blood injection (ABI) around the TMJ as a treatment
for habitual TMJ dislocation was ﬁrst reported by Brachmann
(1964). Several articles followed (Jacobi and Tetsch, 1981; Schulz,
1973), but the technique never gained widespread popularity. ABI
has recently been reintroduced as a treatment for habitual TMJElsevier Ltd. All rights reserved.
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good effects against dislocation.
ABI is a simple technique that can be performed on an outpa-
tient basis, and offers a very safe, simple and effective treatment for
patients categorized as high risk for surgical treatment. Once
injected into the superior compartment of the TMJ and into the
pericapsular tissue, autologous blood is considered to cause scar-
ring and ﬁbrosis (Schultz, 1937). The resulting ﬁbrous tissue causes
a reduction in mandibular movements, stopping habitual TMJ
dislocation of the condyle.
Gulses et al. (2013) also reported that histological ﬁndings
showed that ABI could result in ﬁbrotic changes in the capsule and
retrodiscal ligament of the TMJ in a pig model. Furthermore,
Yoshida et al. (2013) reported that good results were obtained
when 20 patients underwent ABI into the superior compartment
and periarticular capsule.We consider that applying ABI around the
TMJ capsule is the most important factor for success.
Despite the recent reintroduction of ABI (Hegab, 2013; Yoshida
et al., 2013; Güven, 2009), reports regarding magnetic resonance
imaging (MRI) ﬁndings following ABI are scarce (McKelvey, 1950;
Myrhaug, 1951). The aim of this study was thus to investigate
MRI ﬁndings following ABI treatment of habitual TMJ dislocation in
terms of signiﬁcant differences within and/or around tissues of the
TMJ capsule.
2. Materials and methods
Fourteen consecutive patients (4 males, 10 females) who pre-
sented to the First Department of Oral and Maxillofacial Surgery at
Osaka Dental University and were diagnosed with habitual TMJ
dislocationwere included in this prospective study. Mean age at the
time of presentation was 57.0 years (range, 17e82 years). Six cases
involved left-side TMJ dislocation, and 8 cases were right-sided.
Mean duration of symptoms was 32.6 months (range, 2 months e
15 years). Seven patients had concomitant systemic disease
(Table 1).
Patients were diagnosed with TMJ dislocation based on the
following clinical and radiographic criteria (Nitzan, 2002):
1) maximal mouth opening during the event greater thanmaximal
opening;Table 1
Clinical information of examination cases and MRI ﬁndings of ABI.
No Age Sex Side Onset Systematic disease
1 17 y F L 2 y
2 28 y F R 4 m
3 29 y M R 5 y
4 32 y F R 1 y
5 32 y F L 1 y
6 44 y F L 15 y Hashimoto’s disease, Schizophrenia
7 63 y M R 1 y
8 73 y M R 3 m Hydrocephalus
9 73 y M L 3 m Hydrocephalus
10 77 y F R 2 m Dementia, Diabetes
11 78 y F L 6 m Angina pectoris
12 80 y F L 1 y Cerebral infraction, Diabetes
13 81 y F R 6 m Cerebral infraction
14 82 y F R 10 y Cerebral infraction, Parkinson’s disease
m : months, y : years, M : male, F : female, R : right, L : left.
Male : 4 cases, Female : 10 cases.
Right side : 8 cases, Light side : 6 cases.
Type I : Kaneyama et al.’s classiﬁcation Grade 0e3.
Type II : (þ) : appearance of image of sporadic and diffused T2 emphasized around the T
Type III : (þ) : case of decrease in the movable region of the condyle, () : no changings2) computed tomography showing condyle location in front of and
superior to the articular tubercle; and
3) MRI showing the condyle located in front of the articular tu-
bercle during the open-mouth position.
Instead of open surgical intervention, all patients underwent
ABI to the TMJ. All procedures were performed by the same sur-
geon, in the same hospital, and following the same protocol. We
examined the number of dislocation episodes and duration of
symptoms in a medical interview.
ABI was applied to the patient under local anesthesia. After
preparing the patient in the usual manner, the surgeon visually
identiﬁed a line from the tragus to the lateral angle of the eye.
The articular fossa (AF) is found using this line, 10 mm anterior to
the tragus of the ear and 2 mm inferior to the line. Local anes-
thesia of the auricular temporal nerve was applied to the patient,
and a 22-gage needle was inserted into the AF at the identiﬁed
point. After 3 ml of 1% lidocaine was injected, the 22-gage needle
was left for pumping in the AF point. Referring to the 2001 report
by Hasson and Nahlieli, 5 ml of blood was drawn from the
patient’s antecubital fossa, and the syringe was connected to the
previously inserted needle. Approximately 3 ml of blood was
injected into the superior compartment and approximately
2 ml into the pericapsular tissue (anterior, posterior, and
outside).
Antibiotic medication was initiated from 3 days before the
procedure for all patients. After the procedure, patients received
non-steroidal anti-inﬂammatory drugs for analgesia. The patients
were provided with speciﬁc instructions to guide postoperative
rehabilitation and establish controlled mouth opening. After the
ﬁrst month, all patients had restricted mouth opening of 25 mm
and followed a diet limited to soft foods only. We did not perform
intermaxillary wire ﬁxation or use any other speciﬁc appliances to
prevent TMJ dislocation. After 1 year, none of the 14 patients (0%)
had shown any recurrent dislocations of the TMJ. MRI was per-
formed for each of the 14 patients at one hour, four weeks, and
twelve weeks after ABI.
MRI examination was performed using a Signa 1.5-T system (GE
Healthcare, Milwaukee, WI). When MRI examinations of the
opening position of the TMJ were carried out, we used a silicone
block (thickness, 10 mm) to keep the mouth open.Preope One hour Four weeks Twelve weeks
I II III I II III I II III
0 1 þ þ 0  þ 0  þ
0 2 þ þ 0  þ 0  þ
0 3 þ þ 0  þ
0 3 þ þ 0  þ 0  þ
0 1 þ þ 0  þ 0  þ
0 2   0   0  
0 3 þ  0  þ
0 1 þ  0  þ 0  þ
0 3 þ  0  þ 0  þ
0 1  þ 0  þ
0 1 þ þ 0  þ 0  þ
0 1   0  þ 0  
0 1  þ 0  þ
0 1   0  
MJ capsule, () : not emphasized.
.
Fig. 2. The MR imaging of type II expression. Sporadic and diffused T2 weighted image
in the TMJ capsule.
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The ﬁrst was similar to hematoma and/or joint effusion in the
articular capsule of TMJ (type I) Fig. 1. The second type showed
sporadic and diffuse T2 emphasis around the TMJ capsule (type II)
Fig. 2. The third type involved a decrease in the range of mandibular
condyle movement compared to before ABI (type III) Fig. 3.
We evaluated MRI ﬁndings with joint effusion of the capsule
based on the classiﬁcation by Kaneyama et al. (2010), as Grade 0e3.
In MRI ﬁndings of type II, if we could ﬁnd images of sporadic and
diffuse T2 emphasis around the TMJ capsule, the case was regarded
as positive. When no such emphasis was apparent, the case was
considered negative. In comparing MRI ﬁndings between before
and after ABI for type III, cases with a decreased range of condyle
movement were considered positive, and all others were consid-
ered negative.
Control data were obtained by patients (2 men, 12 women) with
a mean age of 55.5 years (range, 24e76 years) who underwent
pumping treatment for temporomandibular disorder (Murakami
et al., 1987). The side contralateral to the side of pumping treat-
ment was investigated for MRI ﬁndings (types I, II and III) before
treatment and after four weeks (Table 2).
All study protocols were approved by the Osaka Dental Uni-
versity Medical Ethics Committee (No. 080134).3. Results
3.1. MRI ﬁndings one hour after ABI
MRI ﬁndings for type I were found in all 14 cases: Grade 0, 0/14
(0%); Grade 1, 8/14 (57.1%); Grade 2, 2/14 (14.3%); and Grade 3, 4/14
(28.6%). For type II, 9 patients (64.3%) were positive and 5 (35.7%)
were negative. For type III, 8 patients were positive (57.1%) and 6
(42.9%) were negative (Table 1).3.2. MRI ﬁndings four weeks after ABI
Four weeks after ABI, 9 patients were examined with MRI. All
type I ﬁndings at this time were Grade 0 (100%). For type II, no
positive cases were found, and all 9 patients (100%) were negative.
For type III, 8 patients (88.9%) were positive and 1 (11.1%) was
negative (Table 1).Fig. 1. The MR imaging of type I expression. T2 weighted image pressing high signal
intensity in the upper articular space.3.3. MRI ﬁndings twelve weeks after ABI
Twelveweeks after ABI, all 14 patients underwentMRI. All type I
ﬁndings were again Grade 0 (100%). For type II, no positive cases
were found, and all 14 patients (100%) were negative. For type III, 11
patients (78.6%) were positive and 3 (21.4%) were negative
(Table 1).
3.4. MRI ﬁndings in control cases
For type I ﬁndings, 4 patients (28.6%) were grade 1 and 10
(71.4%) were grade 0 before pumping treatment of the TMJ. At four
weeks after treatment, 3 patients (21.4%) were grade 1 and 11
(78.6%) were grade 0. For Type II, all patients (14/14, 100%) were
negative both before and after treatment. Similarly, all 14 patients
(100%) showed negative results for type III (Table 2).
4. Discussion
Our previous study described the minimally invasive nature and
positive effects on habitual TMJ dislocation of ABI around the TMJ
capsule (Yoshida et al., 2013). Daif (2010) recently reported ABI to
the TMJ in patients with habitual dislocation as a simple, safe, and
cost-effective technique. In that study, 30 patients with chronic
recurrent TMJ dislocation were randomly divided into two equal
groups: Group A, treated using only 2 ml of ABI into the superior
articular cavity; and Group B, which received 2 ml of ABI to the
superior articular cavity and 1 ml in the pericapsular tissues. At the
end of the 1-year follow-up period, the results of that study showed
that ABI to the superior articular cavity and pericapsular tissues
yielded a higher success rate (80%) than injection into the superior
articular cavity alone (60%). Moreover, the decrease in maximal
mouth opening was larger for Group B than for Group A. MRI
ﬁndings for the joints in Group B only showed the condylar head
posterior to the articular eminence in open position, instead of
being anterior before the injection. In both groups, no destructive
changes to bony components of the joint have been observed.
In those studies (Yoshida et al., 2013; Daif, 2010), minimally
invasive treatment for habitual TMJ dislocation using ABI around
the TMJ capsule was reported as a very safe, simple, and effective
treatment for all patients.
In the present study, 8 of 14 patients had systemic disease
(Table 1). None of the 14 patients experienced any recurrence or
Fig. 3. The MR imaging of type III expression. a: Open position of the preoperation. b: Open position of the postoperation. When compared with a and b, it was detected that
decreasing in the movable range of the mandibular condyle.
Table 2
MRI ﬁndings of control cases.
No Age Sex Affected side Preoperationa Postoperationa
1 24 y F R 0 0
2 27 y F L 0 0
3 33 y F L 1 0
4 50 y F L 0 0
5 53 y F L 2 2
6 56 y F R 0 0
7 56 y M L 0 0
8 60 y F R 0 0
9 61 y F L 1 1
10 64 y F L 1 1
11 70 y M R 0 0
12 73 y F R 0 0
13 74 y F R 1 1
14 76 y F L 0 0
y: years, M: male, F: female, R: right, L : left.
Male: 2 cases, Female: 12 cases.
Right side: 6 cases, Light side: 8 cases.
a Type I MRI expressions based on Kaneyama’s classiﬁcation.
N. Oshiro et al. / Journal of Cranio-Maxillo-Facial Surgery 42 (2014) 1486e1490 1489severe complications in the year following ABI. However, we were
unable to examine in detail the relationship between systematic
disease and speciﬁc MRI ﬁndings. In the future, we intend to
investigate the prognosis and accumulate many more cases of
minimally invasive treatment for habitual TMJ dislocation using ABI
around the TMJ capsule in patients at high risk from surgical
treatment.
In another report, Hasson and Nahlieli (2001) mentioned that
restraining mandibular movement is the key to the success of the
procedure. The pain that follows the injections will also restrain
mandibular movement, permitting the injected blood to settle and
create ﬁbrosis. The present study did not perform intraoral maxil-
lary wire ﬁxation following ABI.
Candirli et al. (2012) investigated the effects of ABI for chronic
recurrent TMJ dislocation using MRI. In that report, 1 month after
injection, TMJ dislocations were not observed in the MRI evalua-
tions of any patient. No signiﬁcant structural change caused by ABI
was observed.
In our study, accumulation similar to joint effusion in the su-
perior TMJ capsule (Kaneyama’s classiﬁcation Grade 1e3) was
observed from one hour after ABI (14/14: 100%).
Nine of the 14 cases revealed ﬁndings similar to sporadic and
diffuse T2 emphasis in tissues around the TMJ (9/14: 64.3%). The
reason such ﬁndings were not evident in the 5 cases was attributedto autologous blood distributing between connective tissues.
Accumulation of injected autologous blood is not always revealed
on MRI, because the blood easily diffuses between sparse connec-
tive tissues.
Type I and II ﬁndings were only evident at one hour after ABI.
After four and twelve weeks, neither ﬁnding was identiﬁed. The
injected autologous blood was thus considered to have been
completely absorbed.
Restricted movement of the condylar head was found in 8 cases
(57.1%) at one hour after ABI. After twelve weeks, this number
increased to 11 (78.6%). When performing MRI, we applied silicone
bite blocks (thickness, 10 mm). This does not represent the
maximum opening position of the TMJ. However, type III ﬁndings
were still expressed. These results suggest that ABI restricts ante-
rior protrusion of the condylar head. From one hour to twelve
weeks after ABI, the number of cases showing restricted condylar
movement increased. We considered that this increase in type III-
positive results was related to the appearance of sporadic and
diffuse T2 emphasis around TMJ tissues (type II-positive results).
This result adds weight to our hypothesis that the presence of
autologous blood around the TMJ capsule is the most important
factor for successful treatment using ABI. In the near future, ABI
around the TMJ capsule might become established as an indepen-
dent treatment for habitual TMJ dislocation. However, this study
only investigated a small number of samples. More detailed clinical
and histopathological studies are therefore warranted.
5. Conclusion
This study found three important types of MRI ﬁnding after ABI.
Our results suggest that injecting autologous blood into tissues
surrounding the TMJ is a very important factor in the success of ABI.
Minimally invasive treatment for habitual TMJ dislocation using ABI
around the TMJ capsule appears to represent a very effective and
safe treatment.
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